Strengthening the reporting of harms of all interventions in clinical trials

Med J Aust. 2022 Nov 21;217(10):502-504. doi: 10.5694/mja2.51755. Epub 2022 Oct 26.

Authors

Christina Abdel Shaheed¹, Christopher G Maher¹, Ann-Mason Furmage², Tammy Hoffmann³, Andrew J McLachlan¹

Affiliations

¹ University of Sydney, Sydney, NSW.
² Consumer Advisory Group, Royal Prince Alfred Hospital, Sydney, NSW.
³ Institute for Evidence-Based Healthcare, Bond University, Gold Coast, QLD.

No abstract available

Keywords: Adverse drug reactions; Adverse events; Clinical trials as topic.

MeSH terms

Adverse Drug Reaction Reporting Systems*
Drug-Related Side Effects and Adverse Reactions*
Humans